Skip to content

Clinical trials

Phase 2 Glucose Intolerance trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glucose Intolerance Phase: Phase 2 Clear all

58 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20044
20051
20061
20073
20082
20098
20102
20116
20121
20132
20141
20153
20162
20181
20193
20202
20216
20234
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed38
Unknown status7
Recruiting5
Terminated3
Active, not recruiting2
Withdrawn2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Guadalajara4
Genfit2
Mayo Clinic2
National Heart, Lung, and Blood Institute (NHLBI)2
Novartis Pharmaceuticals2
University of Minnesota2
AdventHealth Translational Research Institute1
Aphaia Pharma US LLC1
Arete Therapeutics1
Assistance Publique - Hôpitaux de Paris1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glucose Intolerance58
Insulin Resistance18
Diabetes Mellitus, Type 213
Obesity12
Prediabetic State11
Metabolic Syndrome9
Diabetes Mellitus6
Hypertension5
Inflammation3
Obesity, Abdominal3

Trials

Showing 51 to 58 of 58. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.